Back to Search
SARAH SEITZ, M.D.
M.D.
Family Medicine Physician
NPI: 1437239399Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
G55638(CA)
Research & Publications (20)
High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1.
PMID 19415373·Osteoporos Int·2010
8-other
Paget's disease of bone: histologic analysis of 754 patients.
PMID 18767930·J Bone Miner Res·2009
8-other
Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition.
PMID 19491659·Anticancer Drugs·2009
4-observational
Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist.
PMID 18949435·Oncol Rep·2008
8-other
Reconstitution of paired T cell receptor alpha- and beta-chains from microdissected single cells of human inflammatory tissues.
PMID 16882720·Proc Natl Acad Sci U S A·2006
8-other
Effective treatment of pancreatic neuroendocrine tumours transfected with the sodium iodide symporter gene by 186Re-perrhenate in mice.
PMID 19449003·Eur J Nucl Med Mol Imaging·2009
7-preclinical
[Once-yearly administration of zoledronic acid to treat post-menopausal osteoporosis].
PMID 19240992·Unfallchirurg·2009
8-other
Identification of brain- and bone-specific breast cancer metastasis genes.
PMID 19114293·Cancer Lett·2009
8-other
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.
PMID 18629632·Breast Cancer Res Treat·2009
8-other
Impaired gastric acidification negatively affects calcium homeostasis and bone mass.
PMID 19448635·Nat Med·2009
7-preclinical
Inhibition of human non-small cell lung cancers with a targeted cytotoxic somatostatin analog, AN-162.
PMID 19524629·Peptides·2009
7-preclinical
Single nucleotide polymorphisms in human gene icb-1 and breast cancer susceptibility.
PMID 19308812·Cancer Invest·2009
8-other
Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker.
PMID 19115204·Int J Cancer·2009
8-other
SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium.
PMID 18649355·Int J Cancer·2008
7-preclinical
Both subunits of the circadian RNA-binding protein CHLAMY1 can integrate temperature information.
PMID 18567830·Plant Physiol·2008
7-preclinical
Tissue attachment strength and adhesion formation of intraabdominal fixed meshes with cyanoacrylat glues.
PMID 18559298·Eur J Med Res·2008
7-preclinical
Validation of a femoral critical size defect model for orthotopic evaluation of bone healing: a biomechanical, veterinary and trauma surgical perspective.
PMID 18454648·Tissue Eng Part C Methods·2008
7-preclinical
Interaction of poly(rC)-binding protein 2 domains KH1 and KH3 with coxsackievirus RNA.
PMID 18929541·Biochem Biophys Res Commun·2008
8-other
Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors.
PMID 19001433·Mol Cancer Ther·2008
8-other
Circumspect descent prevails in solving random constraint satisfaction problems.
PMID 18832149·Proc Natl Acad Sci U S A·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 401 BICENTENNIAL WAY
SANTA ROSA, CA 95403 - Phone
- (707) 571-4000
Quick Facts
- NPI
- 1437239399
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile